Randomized phase III study of S-1 alone versus S-1 plus docetaxel (DOC) in the treatment for advanced gastric cancer (AGC): The START trial. Background: Chemoradiotherapy (CRT) for locally advanced ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback